Literature DB >> 17420275

GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription.

Yuan-Yeh Kuo1, Zee-Fen Chang.   

Abstract

The induction of Bcl-x(L) is critical for the survival of late proerythroblasts. The erythroid-specific transcriptional network that regulates Bcl-x(L) expression in erythropoiesis remains unclear. The activation of the central erythropoietic transcriptional factor, GATA-1, leads to the early, transient induction of a transcription repressor, Gfi-1B, followed by the late induction of Bcl-x(L) during erythroid maturation in G1ER cells. Chromatin immunoprecipitation assays demonstrated that a constant level of GATA-1 binds to the Bcl-x promoter throughout the entire induction period, while Gfi-1B is transiently associated with the promoter in the early phase. The sustained expression of Gfi-1B abolished GATA-1-induced Bcl-x(L) expression. Here, we present evidence that GATA-1 binds to the noncanonical GATT motif of the Bcl-x promoter for trans-activation. Gfi-1B expressed at increased levels is recruited to the Bcl-x promoter through its association with GATA-1, suppressing Bcl-x(L) transcription. Therefore, the down-regulation of Gfi-1B in the late phase of erythroid maturation is necessary for Bcl-x(L) induction. Furthermore, we show that the inhibition of Bcr-Abl kinase by treatment with imatinib caused the up-regulation of Gfi-1B in K562 cells, where Gfi-1B also cooperated with GATA-1 to repress Bcl-x(L) transcription. Gfi-1B knockdown by RNA interference diminished imatinib-induced apoptosis, while the overexpression of Gfi-1B sensitized K562 cells to arsenic-induced death. These findings illuminate the role of Gfi-1B in GATA-1-mediated transcription in the survival aspect of erythroid cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420275      PMCID: PMC1900040          DOI: 10.1128/MCB.02212-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells.

Authors:  C Sillaber; F Gesbert; D A Frank; M Sattler; J D Griffin
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

Review 2.  The molecular biology of chronic myeloid leukemia.

Authors:  M W Deininger; J M Goldman; J V Melo
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

3.  PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.

Authors:  P Zhang; X Zhang; A Iwama; C Yu; K A Smith; B U Mueller; S Narravula; B E Torbett; S H Orkin; D G Tenen
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

Review 4.  Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.

Authors:  Frank Grosveld; Patrick Rodriguez; Natalia Meier; Sanja Krpic; Farzin Pourfarzad; Petros Papadopoulos; Katarzyna Kolodziej; George P Patrinos; Arnd Hostert; John Strouboulis
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

5.  The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.

Authors:  James C Mulloy; Jörg Cammenga; Karen L MacKenzie; Francisco J Berguido; Malcolm A S Moore; Stephen D Nimer
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

6.  Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.

Authors:  Armin G Jegalian; Hong Wu
Journal:  J Biol Chem       Date:  2001-11-05       Impact factor: 5.157

7.  The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X.

Authors:  C Oetzel; T Jonuleit; A Götz; H van der Kuip; H Michels; J Duyster; M Hallek; W E Aulitzky
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

8.  STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.

Authors:  R P de Groot; J A Raaijmakers; J W Lammers; L Koenderman
Journal:  Mol Cell Biol Res Commun       Date:  2000-05

9.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

Authors:  B J Druker; M Talpaz; D J Resta; B Peng; E Buchdunger; J M Ford; N B Lydon; H Kantarjian; R Capdeville; S Ohno-Jones; C L Sawyers
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

10.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

Authors:  B J Druker; C L Sawyers; H Kantarjian; D J Resta; S F Reese; J M Ford; R Capdeville; M Talpaz
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

View more
  20 in total

Review 1.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

2.  Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.

Authors:  Lothar Vassen; Cyrus Khandanpour; Peter Ebeling; Bert A van der Reijden; Joop H Jansen; Stefan Mahlmann; Ulrich Dührsen; Tarik Möröy
Journal:  Int J Hematol       Date:  2009-04-10       Impact factor: 2.490

3.  GFI1B controls its own expression binding to multiple sites.

Authors:  Eduardo Anguita; Ana Villegas; Francisco Iborra; Aurora Hernández
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

4.  During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool.

Authors:  Arvind Dev; Jing Fang; Pradeep Sathyanarayana; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

5.  BCL2L1 is associated with γ-globin gene expression.

Authors:  Yan Dai; Elmutaz M Shaikho; Jessica Perez; Carolyn A Wilson; Lesley Y Liu; Mitchell R White; John J Farrell; David H K Chui; Paola Sebastiani; Martin H Steinberg
Journal:  Blood Adv       Date:  2019-10-22

6.  Humanized culture medium for clinical expansion of human erythroblasts.

Authors:  Giovanni Migliaccio; Massimo Sanchez; Francesca Masiello; Valentina Tirelli; Lilian Varricchio; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Cell Transplant       Date:  2010-01-06       Impact factor: 4.064

7.  Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis.

Authors:  Yuichiro J Suzuki
Journal:  Cell Signal       Date:  2011-03-01       Impact factor: 4.315

8.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

9.  Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis.

Authors:  Zahra Kadri; Ritsuko Shimizu; Osamu Ohneda; Leila Maouche-Chretien; Sylvie Gisselbrecht; Masayuki Yamamoto; Paul-Henri Romeo; Philippe Leboulch; Stany Chretien
Journal:  PLoS Biol       Date:  2009-06-09       Impact factor: 8.029

10.  Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells.

Authors:  Benoît Laurent; Voahangy Randrianarison-Huetz; Zahra Kadri; Paul-Henri Roméo; Françoise Porteu; Dominique Duménil
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.